Arena Pharmaceuticals Inc (NASDAQ:ARNA)

4.33
Delayed Data
As of Mar 27
 -0.01 / -0.23%
Today’s Change
3.26
Today|||52-Week Range
7.22
+24.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues12.7M27.6M81.4M37.0M
 
 
 
 
 
Cost of Goods Sold8.1M3.7M2.1M7.8M
 
 
 
 
 
Depreciation And Amortization11.1M9.7M8.2M--
 
 
 
 
 
Operating ExpensesGross Income-6.5M14.2M71.1M29.2M
 
 
 
 
 
General Expenses72.8M71.3M94.0M134.5M
 
 
 
 
 
Research And Development58.7M54.1M66.5M100.3M
 
 
 
 
 
Total Operating Expenses92.1M84.7M104.3M142.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-79.3M-57.1M-22.9M-105.3M
 
 
 
 
 
Extraordinary Credit47.0K0.0010.2M4.4M
 
 
 
 
Extraordinary Charge-14.0M-19.8M0.00--
 
 
 
Interest Expense On Debt14.3M9.1M7.1M6.9M
 
 
 
 
 
Other Expenses-1.8M400.0K352.0K47.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-109.2M-85.5M-19.4M-60.5M
 
 
 
 
 
Preferred Dividend-2.3M-2.8M0.00--
 
 
 
Net Income-109.2M-85.5M-19.4M-60.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.2M196.5M218.1M219.7M
 
 
 
 
 
Shares To Calculate EPS Diluted139.2M196.5M218.1M219.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$0.45-$0.09-$0.28
 
 
 
 
 
EPS Diluted-$0.80-$0.45-$0.09-$0.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account